Origins Of Health

Origins Of Health Integrative Health Experts help you get better from Lyme, Co-Infections, PANDAS/PANS, Mycotoxin Illne

Origins Of Health is an Osteopathic holistic medical center specializing in the treatment of chronic fatigue, pain and brain fog. By taking the time to get to the root cause of each patient's problems we help you regain your health and live the life you want.

Before your patient takes their first dose of Tafenoquine, there are three things their blood work is going to show, and...
04/20/2026

Before your patient takes their first dose of Tafenoquine, there are three things their blood work is going to show, and they need to hear it from you first. 🧬

This is not a side effect profile that should catch anyone off guard. These are expected, documented physiological responses to this medication. The problem isn't that they happen. The problem is when clinicians don't prepare patients for them or worse, don't monitor for them at all.

#1 — Hemoglobin will drop. Typically a gram to a gram and a half per deciliter at standard dosing. Push the dose higher, and you're pushing your patient toward significant anemia.

#2 — MCV will rise. Some degree of macrocytosis is normal with this medication. Know your baseline so you can track the change.

#3 — Mild methemoglobinemia is expected. This is the drug working as its pharmacology predicts. It does not mean you stop — it means you monitor.

Long-term safety data shows these changes stabilize over time at standard dosing. But that's not a reason to skip the labs. A CBC, CMP, and methemoglobin level are not optional. They are the minimum standard of responsible use. 💡

Save this and share it with any provider who is prescribing or considering Tafenoquine. Informed consent starts with an informed clinician.

04/13/2026

There's a version of clinical confidence that looks like expertise. And there's a version that's just noise. Knowing the difference matters. 🎯

When a patient comes to you having heard that they need 600 milligrams of Tafenoquine a week, and the only source they can point to is a Facebook group, that's not medicine. That's noise with a confident voice behind it.

Real clinical credibility in this space is built on pharmacology, data, and documented outcomes. Not an anecdote. Not authority. Not how loudly someone makes a claim.

For patients: you have every right to ask your provider not just what they recommend, but why, and what evidence supports it. That's not disrespectful. That's you advocating for yourself.

For clinicians: the standard our patients deserve is one where our confidence is grounded in something we can actually point to. If we can't point to it, we need the humility to say so — and the discipline to go find it.

That's what separates medicine from noise. 💡

If this resonates, save it and share it with a colleague. This is the kind of conversation that moves our field forward.

The most powerful tools are the ones that demand the most respect.Tafenoquine has helped some of the sickest patients I'...
04/10/2026

The most powerful tools are the ones that demand the most respect.

Tafenoquine has helped some of the sickest patients I've ever treated finally turn the corner — people who had been stuck for years, who had tried everything, who had almost given up. That's not nothing. That's everything.

But it works because it's used with precision. Proper screening. Careful dosing. Structured monitoring. Every step intentional.

The moment we start treating it like a blunt instrument — loading doses every week, no labs, no oversight — is the moment we start losing it for everyone who needs it.

It is not a hammer. It never was.

💬 What does it mean to you when a doctor takes the time to truly understand the tool they're using before prescribing it?

A Facebook group is not a clinical trial.I've watched this happen with other treatments. A promising tool gets passed ar...
04/08/2026

A Facebook group is not a clinical trial.

I've watched this happen with other treatments. A promising tool gets passed around in online communities. Doses get inflated. Monitoring gets skipped. Patients start reporting problems. Regulators take notice. And before long, the medication that was genuinely changing lives becomes harder — or impossible — to access.

Confidence is not evidence. Enthusiasm is not data. And a treatment that can't survive peer review probably shouldn't be the foundation of someone's care plan.

The standard exists to protect patients. Let's keep holding it.

💬 Do you think online health communities help or hurt patients navigating complex chronic illness?

04/06/2026

We've watched it happen before. And if we're not careful, we're going to watch it happen again. ⚠️

When a powerful therapy gets used recklessly, without data, without monitoring, without any accountability — regulators notice. Pharmacies hesitate. Insurers restrict. And patients lose access to something that could have changed their lives.

That's not a hypothetical. That's the pattern we've seen play out with other therapies in this space. And Tafenoquine is not immune to it.

400 to 600 milligrams a week, used casually and without structured monitoring, is not a clinical protocol. It's how we hand regulators a reason to take this tool away from the patients who truly need it.

The stakes here are not abstract. They are the real patients sitting in your office who have failed everything else and for whom this medication, used correctly, could finally move the needle.

We protect our patients by protecting this tool. 💡

Share this with every provider in your network who treats tick-borne illness. This is a conversation our field needs to have loudly and openly.

04/03/2026

Preclinical data from Yale just reframed everything we thought we knew about Tafenoquin dosing. 🧬

Dr. Ben-Mamoun's lab showed complete Babesia eradication in mice at 10 mg/kg combined with Atovaquone.

Here's the problem: our standard human dosing is already double that eradication threshold.

Now, that study used an acute babesiosis model — and most of the patients we're working with have chronic babesiosis, which is an entirely different picture. There are no trials for that population yet.

But the data we do have suggests we may only need half of standard dosing — around 100 milligrams per week — to achieve meaningful outcomes.

That's not a reason to throw out the protocol. It's a reason to think harder before you reach for more. 💡

Save this post — and if you know a provider treating chronic Babesia, share it with them.

🎯 The best clinicians I know are not the most aggressive. They're the most precise.It's easy to mistake boldness for com...
04/03/2026

🎯 The best clinicians I know are not the most aggressive. They're the most precise.

It's easy to mistake boldness for competence in medicine. The doctor who throws everything at a problem looks decisive. But decisive isn't the same as right.

The patients I've seen make the most dramatic recoveries didn't get there because someone pushed harder. They got there because someone finally slowed down, looked at the full picture, and matched the right intervention to the right moment.

Right drug. Right dose. Right patient. Right time. That's not caution — that's mastery.

💬 Has a more targeted approach ever made a bigger difference for you than an aggressive one?

04/01/2026

The goal is eradicating the infection. Not creating a new crisis in the process. 🎯

In integrative infection medicine, there's a version of "pushing the dose" that gets mistaken for clinical aggression — when really, it's just a gap in mechanistic understanding.

Real credibility in this space doesn't come from being the most aggressive prescriber in the room.

It comes from monitoring discipline, dosing restraint, and the intellectual humility to say: I don't know yet — so let's study it.

That's the standard that moves our field forward. And that's the standard your patients are counting on you to hold.

If you want to treat complex tick-borne illness at this level of precision, the Lyme Disease Practitioner Certification at LymeTraining.org was built for you. 💡

⚠️ More is not always better — especially in medicine.Somewhere along the way, dose escalation became the default respon...
03/30/2026

⚠️ More is not always better — especially in medicine.

Somewhere along the way, dose escalation became the default response to a patient not improving. If they're not getting better, push higher. Try more. Add another pill.

But pharmacology doesn't care about that logic. A drug with a 15-day half-life doesn't leave the body before the next dose arrives. It stacks. It accumulates. And the stress it puts on an already fragile system compounds with every increase.

More drug doesn't mean more healing. It means more exposure — and eventually, more harm.

💬 Have you ever felt like a treatment was escalated before anyone stopped to ask why it wasn't working?

03/30/2026

Tafenoquine is not your average anti-malarial — and if you're using it without understanding its pharmacology, your patients are at risk. ⚠️

This drug was FDA approved in 2018 with a half-life of 14 to 16 days. It's oxidative, it accumulates in tissues, and its pharmacokinetics are linear.

That last part matters more than most clinicians realize.

Linear pharmacokinetics means there's no magic ceiling. Every dose increase leads to proportionally higher tissue exposure — and proportionally more physiological stress on your patient.

This isn't a clinical opinion. This is hard pharmacological fact.

Understanding this distinction is the difference between a practitioner who gets results and one who inadvertently creates new problems while trying to solve old ones. 💡

Share this with a colleague who treats tick-borne illness — this is the kind of foundational pharmacology that changes how you prescribe.

Here's something that confuses practitioners: antiparasitic treatments sometimes work even when stool tests come back ne...
03/23/2026

Here's something that confuses practitioners: antiparasitic treatments sometimes work even when stool tests come back negative.

Does that mean everyone secretly has parasites that tests are missing?

Not necessarily. And here's why that matters 👇

A study of returning travelers with persistent GI symptoms and negative stool tests found that 69% improved with empirical antiparasitic treatment.

But the authors never claimed this proved parasites were present in every case.

So what's happening? The literature supports several plausible mechanisms:

1. Immune Modulation - Drugs like ivermectin have anti-inflammatory properties beyond just killing worms

2. Microbiome Modulation - Treating organisms like Blastocystis can reshuffle gut flora, sometimes leading to improvement

3. Host-Parasite-Microbiota Interactions - Complex interactions between all three systems can create clinical changes

4. Post-Infectious Phenomena - Low residual infection or dysregulated gut-immune axis responding to treatment

This is fascinating because it shows treatments can work through mechanisms we don't fully understand.

But—and this is critical—that's not permission to claim everyone has parasites without evidence.

Stay curious. Stay honest. And separate what you know from what you're guessing.

💾 Save this post for reference.

📺 Watch the full video on YouTube - link in bio for the complete breakdown.

If 90% of people getting colonics have visible parasites in the water, this would be the most important public health fi...
03/16/2026

If 90% of people getting colonics have visible parasites in the water, this would be the most important public health finding of our lifetime.

Not this decade. Not this century. Ever.

So here's my challenge to colleagues making this claim 👇

Do the work.

Collect the material. Preserve it properly. Send it to a lab with trained parasitologists who can do microscopy, antigen testing, and DNA confirmation.

Then publish the findings.

If those specimens come back confirmed as parasites? That changes everything. Skeptics would have to engage with the data. The field would shift overnight.

But here's what actually happens: when people submit these "rope worms" and structures to labs, they consistently come back as mucus, sloughed intestinal tissue, or debris.

Not parasites.

Visual identification without lab confirmation isn't science. And we can't build treatment protocols on what something "looks like."

I'm not trying to dismiss clinical observations. I'm asking for the evidence that turns observations into facts.

If you're seeing something revolutionary, prove it. That's how we advance the field—with data that stands up to scrutiny.

🔬 Share this with a colleague who's heard these claims.

📺 Watch the full video on YouTube - link in bio for the complete breakdown.

Address

27 Main Street
Hebron, CT
06248

Opening Hours

Monday 8:45am - 5pm
Tuesday 8:45am - 5pm
Wednesday 8:45am - 5pm
Thursday 8:45am - 5pm

Telephone

+18604387096

Website

Alerts

Be the first to know and let us send you an email when Origins Of Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Origins Of Health:

Shortcuts

Share

Category